The metabolic syndrome (MetS) represents a clustering of risk factors for cardiovascular disease (CVD) and Type 2 diabetes (T2DM). 1 Over the years there has been much discussion on this syndrome, ranging from its clinical definition to which factors are solely responsible for its aetiology. While insulin resistance and excessive adiposity play key roles, the pathogenesis of the syndrome is still not well understood.
In a recent review, we found that many traditional and emerging risk factors associated with MetS showed some evidence of exerting their influence through the adipocytokine, adiponectin. 2 We raised the question whether adiponectin may be the mechanistic key to the risk of MetS. This view was schematically depicted through a series of unidirectional links between potential risk factors and adiponectin through to systemic inflammation, insulin sensitivity and then MetS. 2 We accept that some of these relationships maybe bi-directional, as, for example, insulin resistance may be responsible for increased inflammatory cytokine production 3 and vice versa.
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However, we disagree with Kawada's assertion that all the references we cited did not show evidence of association between interlinked events in that scheme. 7 In fact, since the acceptance of our article, further confirmation in favour of the inverse association between adiponectin and systemic inflammation, [8] [9] [10] between inflammation and insulin sensitivity [11] [12] [13] and between sensitivity and MetS 13-15 has emerged. As stated in the conclusions of our paper, higher quality evidence, possibly through randomised controlled trials, are necessary to cement this putative framework. Kawada 7 in his letter also opined that the Matsuzawa et al. 16 model, which depicted visceral adiposity as the central feature, was the preferred way forward. We cannot discount a role for visceral adiposity, as waist circumference, a marker of visceral adiposity, is one of the five consensus features of MetS. 1 However, even after controlling for adiposity, there still remains a substantial unexplained risk of MetS. [17] [18] [19] [20] The phenomena of obese but otherwise metabolically healthy individuals would also suggest that MetS has a more complicated aetiology than can be solely attributed to excess adiposity. Moreover, consistent inverse links between adiponectin levels and all individual components of the MetS have been observed, 21 even after controlling for adiposity. 20, 22 We thank Kawada 7 for his interest and comments on our paper. In an area where improved management and preventative strategies are paramount, it is good to stimulate discussion on the aetiopathogenesis of this global problem.
